Brazil to produce AstraZeneca’s experimental coronavirus vaccine
British drug-maker already carrying out large-scale, mid-stage human trials
![Health official said country will initially produce some 30 million doses of the vaccine, half by December and half by January of next year](https://static.independent.co.uk/s3fs-public/thumbnails/image/2020/06/27/16/coronavirus-vaccine.jpg)
Support truly
independent journalism
Our mission is to deliver unbiased, fact-based reporting that holds power to account and exposes the truth.
Whether $5 or $50, every contribution counts.
Support us to deliver journalism without an agenda.
![Louise Thomas](https://static.independent.co.uk/static-assets/support-us/louise-thomas.png)
Louise Thomas
Editor
Brazil announced on Saturday that it had signed a $127m (£102m) agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the Covid-19 pandemic.
The AstraZeneca vaccine is considered the world’s leading candidate and most advanced in terms of development to obtain licensure and become an official vaccine against the disease, according to the World Health Organisation.
The British drug-maker is already carrying out large-scale, mid-stage human trials of the vaccine, which was developed by researchers at Oxford University.
Elcio Franco, Brazil’s number two public health official, said in a press conference that the country will initially produce some 30 million doses of the vaccine, half by December and half by January of next year.
Mr Franco said Brazil is paying for the vaccine but is aware of the risk, in case the vaccine does not pass all necessary licensure requirements or another vaccine obtains approval faster.
The vaccine will be produced by Brazil’s Fundação Osvaldo Cruz, also known as Fiocruz, the country’s leading public health organisation, Mr Franco said.
Brazil is the world’s second most affected country by the coronavirus pandemic, with more than 1.2 million confirmed cases as of Friday and more than 55,000 deaths.
Right-wing president Jair Bolsonaro has been widely criticised for this response to the pandemic. He has dismissed the severity of the disease and has shown indifference to the rising death toll while also pushing treatment using an unproven anti-malaria drug.
Reuters
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments